1 completed, 1 enrolling by invitation, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Enrolling by invitation 1, Withdrawn 1 |
Follow Liver Transplant Rejection: new trials by email Literature Review of Liver Transplant Rejection trials Research Report on Liver Transplant Rejection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients Prograf, Envarsus - Liver Transplant Rejection, Immune System Suppression | Phase 4 | Enrolling by invitation | University Health Network, Toronto | 40 | 2024-01-01 | 2024-12-11 |
| Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients Erythropoietin - Liver Transplant Rejection | Phase 4 | Completed | Northwestern University | 9 | 2022-02-18 | 2026-10-29 |
| Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects Budesonide, Tacrolimus（FK506）, Mycophenolate Mofetil - Acute Cellular Graft Rejection, Liver Transplant Rejection | Phase 4 | Withdrawn | Montefiore Medical Center | 2019-01-01 | 2019-09-23 |
Diabetes Mellitus (1) · Hypertension (1) · Infections (1) · Renal Insufficiency (1)
Cardiovascular Diseases (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1) · Vascular Diseases (1)
Tacrolimus (2) · Budesonide (1) · Erythropoietin (1) · Mycophenolic Acid (1) · Prednisone (1)
Montefiore Medical Center (1) · Northwestern University (1) · University Health Network, Toronto (1)
Canada (1) · United States (1)
Josh Levitsky, MD (1) · Nazia Selzner, MD (1)